DSM moves to grow health and nutrition capabilities through postbiotic producer Adare Biome in €275M
date:Apr 20, 2023
dients such as Lactol a product containing the postbiotic Lactobacillus LB into its B2C offerings. The company states that the offering has been shown to relieve upset stomachs and aid digestion.

DSM would be the ideal company to take Adare Biome to a new level and realize the growth potential of postbiotics, underscores Sellig.

A growing market
DSM further states the acquisition will allow it to develop the applicability of the B2B ingredient for medical nutrition, early life nutrition, die
4/7 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
01/07 23:34